Esser, P., Heimann, K., Bartz-schmidt, K
As shown in Figure 3A, APP/PS1 mice exhibited remarkable synaptic loss compared to WT control mice
Other ingredients Water, methylpropanediol, glycerin, niacinamide, propanediol, 1,2-hexanediol, glycereth-26, polyglycerin-3, butylene glycol, carbomer, arginine, sodium ascorbyl phosphate, allantoin, polyglyceryl-10 laurate, hydrogenated lecithin, ethylhexylglycerin, xanthan gum, glutathione, dipropylene glycol, disodium edta, coptis japonica root extract, fragrance, methyl diisopropyl propionamide, panthenol, sodium hyaluronate, sodium polyacrylate, glyceryl acrylate/acrylic acid copolymer, pvm/ma copolymer, ceramide np, hippophae rhamnoides water, ascorbic acid, 3-o-ethyl ascorbic acid, acetyl glucosamine, tocopherol, lecithin, polysorbate 20, biotin, cyanocobalamin, folic acid, pyridoxine, riboflavin, thiamine hcl, retinol
Tofacitinib ameliorates murine lupus and its associated vascular dysfunction